Yahoo
HKSE - Delayed Quote HKD

Bayzed Health Group Inc (2609.HK)

2.705 +0.035 (+1.31%)
As of 10:58:00 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2609.HK
  • Previous Close 2.670
  • Open 2.735
  • Bid 2.695 x --
  • Ask 2.710 x --
  • Day's Range 2.630 - 2.740
  • 52 Week Range 2.525 - 7.120
  • Volume 429,000
  • Avg. Volume 3,947,314
  • Market Cap (intraday) 3.566B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 135.25
  • EPS (TTM) 0.020
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Bayzed Health Group Inc operates and manages a network of hospitals that provides oncology medical and healthcare services in the People's Republic of China. The company offers screening, diagnosis, treatment, and rehabilitation services. It also provides hospital management services; and supplies pharmaceuticals, medical equipment, and consumables. The company was founded in 2017 and is headquartered in Beijing, the People's Republic of China. The company was founded in 2017 and is based in Beijing, China.

www.bayzedhealthcare.com

2,036

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2609.HK
29.00%
HANG SENG INDEX (^HSI)
3.90%

1-Year Return

2609.HK
61.63%
HANG SENG INDEX (^HSI)
5.03%

3-Year Return

2609.HK
48.48%
HANG SENG INDEX (^HSI)
39.44%

5-Year Return

2609.HK
48.48%
HANG SENG INDEX (^HSI)
0.96%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.58%

  • Return on Assets (ttm)

    1.30%

  • Return on Equity (ttm)

    1.85%

  • Revenue (ttm)

    1.13B

  • Net Income Avi to Common (ttm)

    29.08M

  • Diluted EPS (ttm)

    0.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    562.91M

  • Total Debt/Equity (mrq)

    33.04%

  • Levered Free Cash Flow (ttm)

    -198.85M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: